Solving for Missingness: Enhancing the Utility of Real-World Data for Oncology Research
Real-world data (RWD) from electronic health records (EHRs) is increasingly recognized as a powerful asset for oncology research. It enables stakeholders across industry and academia to evaluate treatment patterns, assess comparative effectiveness, identify safety signals, and inform regulatory and market access strategies. RWD has supported external control arms, augmented clinical trial enrollment, and generated post-marketing […]
